Both in Pharmaceuticals
Viatris vs BridgeBio Pharma
Over the past year VTRS returned +83.2% and BBIO returned +26.9%; their daily moves had a correlation of 0.17.
VTRS +83.2% BBIO +26.9%Growth of $1, one year, split-adjusted
| Metric | VTRS | BBIO |
|---|---|---|
| Price | $19.22 | $77.89 |
| Market cap | $22.08B | $15.17B |
| Today | +1.59% | +5.21% |
| 1 month | +9.6% | +16.3% |
| 6 months | +20.5% | +14.4% |
| Year to date | +54.4% | +1.8% |
| 1 year | +82.5% | +25.7% |
| Revenue growth (YoY) | +4.9% | +192.6% |
| Gross margin | 38.8% | 94.2% |
| Net margin | −3.2% | −23.5% |
| P/E (TTM) | — | — |
| Price / sales | 1.5× | 16.0× |
| Net cash | -$12.46B | -$938.6M |
| Dividend yield | 2.50% | — |
| Volatility (60d) | 23.4% | 34.1% |
| Short % of float | 3.3% | 12.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).